Upadacitinib is safe and effective for treatment of non-radiographic axial spondyloarthritis
1. Significantly more patients in the upadacitinib group achieved ASAS40 response at week 14 compared to the placebo group. 2. ...
1. Significantly more patients in the upadacitinib group achieved ASAS40 response at week 14 compared to the placebo group. 2. ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.